Issues concerning the monitoring of statin therapy in hypercholesterolemic subjects with high plasma lipoprotein(a) levels

Lipids

Volumn 37, Issue 5, 2002, Pages 439-444

  Scanu, Angelo M ^a   Hinman, Janet ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOASSAY; CHOLESTEROL; IMMUNOLOGY;

ULTRACENTRIFUGAL ANALYSIS;

PROTEINS;

ATORVASTATIN; CERIVASTATIN; LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; SIMVASTATIN; STATIN; HEPTANOIC ACID DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; PYRIDINE DERIVATIVE; PYRROLE DERIVATIVE;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG MONITORING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA; IMMUNOCHEMISTRY; LIPID COMPOSITION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; TREATMENT OUTCOME; ULTRACENTRIFUGATION; VALIDATION PROCESS; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; MIDDLE AGED;

ADULT; AGED; ANTICHOLESTEREMIC AGENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPTANOIC ACIDS; HUMANS; HYPERCHOLESTEROLEMIA; LIPOPROTEIN(A); LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PRAVASTATIN; PYRIDINES; PYRROLES; SIMVASTATIN;

EID: 0035999523     PISSN: 00244201     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11745-002-0915-1     Document Type: Article

References (29)

1. Apolipoprotein(a): Structure and biology
2. Lipoprotein (a): Hetero-geneity and biological relevance
3. Lipoprotein(a)
4. Lipoprotein(a)
5. Lipoprotein(a), Friedewald formula and NCEP guidelines, National cholesterol education program
6. Measurement of low-density-lipoprotein cholesterol
7. Estimation of the distribution of low density lipoprotein cholesterol in plasma without the use of the preparative centrifuge
8. Precautionary measures for collecting blood destined for lipoprotein isolation
9. Enzyme-linked immunoassay for Lp(a)
10. Heterogeneity of human plasma Lp(a)
11. Heterogeneity of human plasma Lp(a): Isolation and characterization of the lipoprotein subspecies and their apoproteins
12. Molecular basis of apolipoprotein(a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis
13. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal
14. Changes in plasma triglyceride levels shift lipoprotein(a) density in parallel with that of low-density lipoprotein independently of apolipoprotein(a) size
15. An improved detection system applied to the study of serum lipoproteins after single-step density gradient ultra-centrifugation
16. Functional and metabolic differences between elastase-generated fragments of human lipoprotein(a) and apolipoprotein(a)
17. Quantification of lipoprotein(a) in plasma by assaying cholesterol in lectin-bound plasma fraction
18. Lipoprotein(a) and coronary heart disease
19. Disorders of the biogenesis and secretion of lipoproteins containing the B apolipoproteins
20. Lowered serum cholesterol and low mood
21. Serum lipid and mood in working men and women in Sweden
22. Association of low serum total cholesterol with major depression and suicide
23. The association of low serum cholesterol with suicidal behaviours: New hypotheses for the missing link
24. Low serum cholesterol and risk of suicide
25. Low serum cholesterol in violent but not in non-violent suicide attempters
26. Low cholesterol and violent crime
27. Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (adult treatment panel III)
28. Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy
29. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality